Evidence map›Paper›PMID 41607792›Full record

ArticleFrontiers in immunology2025

Harmonisation of switched memory B cell analysis for improved CVID diagnosis and classification.

Malicorne Buysse, Jana Neirinck, Ciel De Vriendt, Filomeen Haerynck, Martín Pérez-Andrés, Alberto Orfao, Mattias Hofmans, Carolien Bonroy

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Malicorne Buysse *Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
Jana Neirinck *Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
Ciel De VriendtDepartment of Haematology, Ghent University Hospital, Ghent, Belgium.
Filomeen HaerynckDepartment of Pediatric Pulmonology and Immunology and Primary Immunodeficiency (PID) Research Laboratory, Ghent University Hospital, Ghent, Belgium.
Martín Pérez-AndrésCancer Research Centre (Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Cancer Research Institute of Salamanca (USAL-CSIC), Spanish Biomedical Research Centre in Cancer (CIBERONC) CB16/12/00400, Institute for Biomedical Research of Salamanca (IBSAL), Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca, Spain.
Alberto OrfaoCancer Research Centre (Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Cancer Research Institute of Salamanca (USAL-CSIC), Spanish Biomedical Research Centre in Cancer (CIBERONC) CB16/12/00400, Institute for Biomedical Research of Salamanca (IBSAL), Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca, Spain.
Mattias Hofmans *Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
Carolien Bonroy *Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

common variable immunodeficiency (CVID)ESIDEUROclassEuroFlow (EF)flow cytometry (FCM)harmonisation

Identifiers

PMID41607792
PMCPMC12835365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.